The Accelerating Clinical Trials (ACT) Consortium Contract Working Group has developed the Governing Participating Site Agreement for Tri-Council Funded Studies: Interventional and Regulated (gPSA Regulated).

Purpose:

This agreement is designed to streamline contract negotiations for inter-institutional, Health Canada–regulated clinical trials funded by the Tri-Council Agencies (CIHR, NSERC, SSHRC). By establishing a pre-negotiated, legally binding framework, it aims to improve efficiency and accelerate study start-up timelines for academic and affiliated healthcare institutions/health authorities participating in these studies. The gPSA-Regulated has provisions appropriate for using a study drug or device in an academic clinical trial.

Agreement Structure:

The agreement includes two key components:
1) Agreement: A pre-negotiated, legally binding contract that outlines standard clauses and conditions. Parties agree to the terms in full unless specific changes are outlined in the accompanying Study Letter.

2) Study Letter: A project-specific document for each trial conducted under the agreement, which includes:

  • Study-specific details and identifiers
  • Optional clauses tailored to trial characteristics
  • A section for any permitted modifications to the Governing Agreement
Key Benefits:
  • Reduces the need for full re-negotiation for every new study
  • Enables focused review of only study-specific details
  • Promotes consistency in legal and governance terms across academic organizations and health authorities nationwide
Who Should Sign On:
  • Institutions eligible to receive Tri-Council funding for regulated, interventional studies
  • Any other Institution acting as participating sites in such studies
How to Become an Adoptee:
 
The Research Institute of the McGill University Health Centre
Kingston Health Sciences Centre Research Institute/Kingston Health Sciences Centre
MICYRN
CHU de Québec-Université Laval
The Hospital for Sick Children (Sick Kids)
Holland Bloorview Kids Rehabilitation Hospital
IWK Health
Shared Health
Hamilton Health Sciences Corporation
Research St. Joseph’s – Hamilton o/a The Research Institute of St. Joe’s Hamilton
Bruyére Health Research Institute
London Health Sciences Centre Research Inc. dba. London Health Sciences Centre Research Institute (LHSCRI)
Lawson Research Institute (Lawson)
Ottawa Hospital Research Institute
Dalhousie University
The University of British Columbia
Provincial Health Services Authority (on behalf of BC Cancer)
Provincial Health Services Authority (on behalf of BC Children’s Hospital and BC Women’s Hospital & Health Centre)
Providence Health Care Society
Vancouver Coastal Health Authority
University of Alberta
University of Manitoba
McMaster University
Fraser Health Authority
Vancouver Island Health Authority
Unity Health Toronto
University Health Network
The University of Western Ontario
Sinai Health System
Queen’s University at Kingston
Institut du Savoir Montfort
Providence Care Centre
Université Laval
Sunnybrook Research Institute
CancerCare Manitoba
Health Sciences North Research Institute
Winnipeg Regional Health Authority
SANTÉ QUÉBEC, legal person established in the public interest constituted under an Act respecting the governance of the health and social services system, (CQLR c. G-1.021), acting through its institution CENTRE HOSPITALIER DE L’UNIVERSITÉ DE MONTRÉAL (CHUM), located at 850 Saint-Denis St, Pavilion S, Montréal, Quebec, H2X 0A9, Canada, represented for the purposes hereof by Sylvain Baillet, Director of Research and Innovation of CHUM, duly authorized in accordance with Santé Québec’s by-laws
Trek Health Research
Thunder Bay Regional Health Research Institute
Thunder Bay Regional Health Sciences Centre
SOUTHLAKE HEALTH
Provincial Health Authority, operating as NL Health Services
Oak Valley Health
Institut de recherches cliniques de Montréal
CISSS de Chaudière-Appalaches
Santé Québec – Centre intégré de santé et de services sociaux de l’Outaouais
CIUSSS l’EST-del’Ile-de-Montreal